Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi ® During Pregnancy, in United States (US)
Condition: Meningococcal Infection Intervention: Biological: Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine Sponsor: Sanofi Pasteur, a Sanofi Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2021 Category: Research Source Type: clinical trials
Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants
Condition: Meningococcal Immunisation Interventions: Drug: Multicomponent Meningococcal B Vaccine; Drug: Meningococcal Group B Vaccine MenB; Drug: Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed); Drug: Placebo; Drug: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine Sponsor: Sanofi Pasteur, a Sanofi Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2021 Category: Research Source Type: clinical trials
